feed,title,long_url,short_url
Benzinga,iTeos to Participate in Upcoming Investor Conferences in November,https://www.benzinga.com/pressreleases/20/11/g18237088/iteos-to-participate-in-upcoming-investor-conferences-in-november,https://j.mp/2GAj4Es
Benzinga,Caladrius Biosciences Provides Corporate Update and Reports 2020 Third Quarter Financial Results,https://www.benzinga.com/pressreleases/20/11/g18237086/caladrius-biosciences-provides-corporate-update-and-reports-2020-third-quarter-financial-results,https://j.mp/366Vjg2
Benzinga,CymaBay Reports Third Quarter 2020 Financial Results and Provides Corporate Update,https://www.benzinga.com/pressreleases/20/11/g18237066/cymabay-reports-third-quarter-2020-financial-results-and-provides-corporate-update,https://j.mp/3euZwxA
Benzinga,Oportun Completes Sale of Subordinate Asset-Backed Securities,https://www.benzinga.com/pressreleases/20/11/g18237062/oportun-completes-sale-of-subordinate-asset-backed-securities,https://j.mp/2HZC3co
Benzinga,Lam Research Corporation Announces $5 Billion Share Repurchase Authorization and Declares Quarterly Dividend,https://www.benzinga.com/pressreleases/20/11/g18237057/lam-research-corporation-announces-5-billion-share-repurchase-authorization-and-declares-quarterly,https://j.mp/32ih8Ib
Benzinga,Sarepta Therapeutics Announces Third Quarter 2020 Financial Results and Recent Corporate Developments,https://www.benzinga.com/pressreleases/20/11/g18237052/sarepta-therapeutics-announces-third-quarter-2020-financial-results-and-recent-corporate-developme,https://j.mp/32h3wNg
Benzinga,"ICU Medical, Inc. Announces Third Quarter 2020 Results and Updates Fiscal Year 2020 Guidance",https://www.benzinga.com/pressreleases/20/11/g18237050/icu-medical-inc-announces-third-quarter-2020-results-and-updates-fiscal-year-2020-guidance,https://j.mp/3mUitgi
Benzinga,"Aziyo Biologics to Report Third Quarter 2020 Financial Results on Thursday, November 19, 2020",https://www.benzinga.com/pressreleases/20/11/g18237045/aziyo-biologics-to-report-third-quarter-2020-financial-results-on-thursday-november-19-2020,https://j.mp/3k1oKFg
Benzinga,Fluidigm Announces Third Quarter 2020 Financial Results,https://www.benzinga.com/pressreleases/20/11/g18237028/fluidigm-announces-third-quarter-2020-financial-results,https://j.mp/3mYQvQK
Benzinga,"Peloton Interactive, Inc. Reports First Quarter Fiscal 2021 Financial Results",https://www.benzinga.com/pressreleases/20/11/g18237025/peloton-interactive-inc-reports-first-quarter-fiscal-2021-financial-results,https://j.mp/351kYrd
Benzinga,"PDS Biotechnology Appoints Renowned Oncologist Otis Brawley, M.D. to its Board of Directors",https://www.benzinga.com/pressreleases/20/11/g18237024/pds-biotechnology-appoints-renowned-oncologist-otis-brawley-m-d-to-its-board-of-directors,https://j.mp/2UaWxkV
Benzinga,"iMedia Brands Sets Third Quarter 2020 Conference Call for Tuesday, November 24, 2020, at 8:30 a.m. ET",https://www.benzinga.com/pressreleases/20/11/g18237023/imedia-brands-sets-third-quarter-2020-conference-call-for-tuesday-november-24-2020-at-8-30-a-m-et,https://j.mp/2TX6aDp
Benzinga,GenMark Diagnostics to Participate in the Canaccord Virtual MedTech & Diagnostics Forum,https://www.benzinga.com/pressreleases/20/11/g18237019/genmark-diagnostics-to-participate-in-the-canaccord-virtual-medtech-diagnostics-forum,https://j.mp/36cj7zb
Benzinga,Geron Corporation Reports Third Quarter 2020 Financial Results and Current Events,https://www.benzinga.com/pressreleases/20/11/g18237016/geron-corporation-reports-third-quarter-2020-financial-results-and-current-events,https://j.mp/3mUttdB
Benzinga,"Solar Capital Ltd. Announces Quarter Ended September 30, 2020 Financial Results; Declares Quarterly Distribution of $0.41 Per Share for Q4, 2020",https://www.benzinga.com/pressreleases/20/11/g18237015/solar-capital-ltd-announces-quarter-ended-september-30-2020-financial-results-declares-quarterly-d,https://j.mp/3l16Q6E
